Imaging Modalities Related to Cardiac Involvement in Systemic Sclerosis
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.046400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von George Markousis-Mavrogenis und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Heidelberg Germany. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Cardiac Imaging Techniques, Heart Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben.
Abstract (Originalsprache)
Systemic sclerosis (SSc) is a chronic rheumatic disease characterized by the unique pathogenetic triad of microvasculopathy, autoimmunity, and fibrosis leading to significant morbidity/mortality. SSc has an annual incidence of 0.6 to 5.6/100 000, affects predominantly women and remains the most lethal of rheumatic diseases being the direct cause of death in >50% of patients. SSc with diffuse cutaneous involvement is defined as skin thickening proximal to the elbows/knees, whereas the limited form denotes cutaneous involvement limited to the distal extremities. Pulmonary fibrosis, pulmonary hypertension, and cardiac inflammation/fibrosis, although varying widely among patients in terms of severity, represent the main causes of death. Primary heart involvement occurs in the majority of patients at some disease stage but is overlooked. It may precede SSc diagnosis and should be carefully monitored using laboratory and imaging biomarkers. Among imaging biomarkers, echocardiography and cardiac magnetic resonance are the most commonly used. Echocardiography can provide functional information of both ventricles and assessment of pulmonary artery pressure. Additionally, strain echocardiography and cardiac magnetic resonance feature tracking can detect early systolic dysfunction before ejection fraction alterations take place. However, cardiac magnetic resonance, by providing functional assessment in parallel with tissue characterization, is the only imaging modality that has the potential to reveal early myocardial inflammation/replacement/diffuse fibrosis and coronary microvascular disease before any systolic alteration takes place. Prospective, multicenter studies that are currently under way will clarify the role of cardiac magnetic resonance in diagnosis, prognosis, and treatment decisions and will facilitate the conception of new imaging‐based guidelines for cardiac involvement in SSc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Heidelberg Germany.
- Research Institute of Maternal and Child Health and Precision Medicine, National and Kapodistrian University of Athens Medical School Aghia Sophia Children's Hospital Athens Greece.
- First Department of Propaedeutic Internal Medicine National and Kapodistrian University of Athens Medical School Athens Greece.
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases IRCCS San Raffaele Hospital Milan Italy.
- Athens Medical Center P. Faliro Athens Greece.
ORCID-Profile: George Markousis-Mavrogenis, Sophie I Mavrogeni
Zitieren
APA
Markousis-Mavrogenis, G., Sfikakis, P. P., Matucci-Cerinic, M., & Mavrogeni, S. I. (2026). Imaging Modalities Related to Cardiac Involvement in Systemic Sclerosis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.046400
Vancouver
Markousis-Mavrogenis G, Sfikakis PP, Matucci-Cerinic M, Mavrogeni SI. Imaging Modalities Related to Cardiac Involvement in Systemic Sclerosis. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.046400
BibTeX
@article{MarkousisMavrogenis2026,
author = {Markousis-Mavrogenis, George and Sfikakis, Petros P and Matucci-Cerinic, Marco and Mavrogeni, Sophie I},
title = {Imaging Modalities Related to Cardiac Involvement in Systemic Sclerosis},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.046400}
}
EUVIMED